Early Cancer-Detection Startup GRAIL is Reportedly Trying to Raise More Money
Only a few months after GRAIL raised a record-breaking $900 million in its Series B funding round, the company is looking for further funding. Focused on early cancer detection, GRAIL also raised $100 million last year to develop its blood testing technology. The current search for funding is focused on sovereign funds. Early talks with Mubadala and Softbank, the $125 billion sovereign fund and private equity firm, suggests that these may be sources of further incoming monies. GRAIL’s parent company Illumina may also provide GRAIL with...